Israel’s Betalin Therapeutics (see here previously) is to receive capital from the European Innovation Council (EIC) fund. The funding will advance human trials of its biological pancreas that can produce insulin in the body independently, thus making injections unnecessary. https://www.calcalistech.com/ctech/articles/0,7340,L-3912996,00.html

I reported previously (Dec 2015) on Israel’s Betalin Therapeutics, which has developed an insulin-producing micro pancreas that can be implanted into the body of diabetics. Betalin has since won startup awards in Tel Aviv and China and has just raised … Continue reading →

Israel’s Betalin has significantly increased the lifetime of pancreatic beta cells transplanted into diabetics in order to produce insulin. This has been achieved by simultaneously transplanting an Engineered Micro Pancreas (EMP) to sustain the cells. http://www.globes.co.il/en/article-israeli-startup-aims-to-end-insulin-injections-1001086686 http://www.betalintherapeutics.com/